“EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric glycopeptide use in neutropenic fever”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022039, Apr. 2022, doi: 10.4084/MJHID.2022.039.